These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1504394)

  • 1. Development of a questionnaire for detecting potential adverse drug reactions.
    Corso DM; Pucino F; DeLeo JM; Calis KA; Gallelli JF
    Ann Pharmacother; 1992; 26(7-8):890-6. PubMed ID: 1504394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
    Lorimer S; Cox A; Langford NJ
    J Clin Pharm Ther; 2012 Apr; 37(2):148-52. PubMed ID: 21592157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of immunotherapy adverse events in patient information leaflets and development of an interface terminology for outpatients' monitoring.
    Zini EM; Lanzola G; Quaglini S; Cornet R
    J Biomed Inform; 2018 Jan; 77():133-144. PubMed ID: 29269275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Matthews EJ; Kruhlak NL; Weaver JL; Benz RD; Contrera JF
    Curr Drug Discov Technol; 2004 Dec; 1(4):243-54. PubMed ID: 16472241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized surveillance of adverse drug events in hospital patients.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    JAMA; 1991 Nov; 266(20):2847-51. PubMed ID: 1942452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data.
    Layton D; Heeley E; Shakir SA
    J Clin Pharm Ther; 2004 Apr; 29(2):171-81. PubMed ID: 15068407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription-event monitoring and reporting of adverse drug reactions.
    Heeley E; Riley J; Layton D; Wilton LV; Shakir SA
    Lancet; 2001 Dec; 358(9296):1872-3. PubMed ID: 11741629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes.
    Hoffman KB; Dimbil M; Kyle RF; Tatonetti NP; Erdman CB; Demakas A; Chen D; Overstreet BM
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1134-43. PubMed ID: 26679963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
    Schäublin M
    Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of a computerized adverse drug event monitor using a hospital information system.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    Hosp Pharm; 1992 Sep; 27(9):774, 776-9, 783. PubMed ID: 10121426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What information is given on adverse drug reactions from new drugs?].
    Eldholm RS; Bergheim TS; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2414-7. PubMed ID: 14562773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and clinical gains of nurse-led medication monitoring profiles.
    Gabe ME; Jordan SE
    J Nurs Manag; 2014 Apr; 22(3):331-49. PubMed ID: 23701013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting adverse experiences related to drugs: an ontology-based tool to help the citizens.
    De Lazzari C; Battaglia M; Pisanelli DM
    AMIA Annu Symp Proc; 2008 Nov; ():923. PubMed ID: 18998793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a database and processing method for detecting hematotoxicity adverse drug events.
    Shimai Y; Takeda T; Manabe S; Teramoto K; Mihara N; Matsumura Y
    Stud Health Technol Inform; 2015; 210():65-9. PubMed ID: 25991103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group.
    Emerson A; Martin RM; Tomlin M; Mann RD
    Pharmacoepidemiol Drug Saf; 2001; 10(2):95-103. PubMed ID: 11499859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural language processing to identify adverse drug events.
    Gysbers M; Reichley R; Kilbridge PM; Noirot L; Nagarajan R; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2008 Nov; ():961. PubMed ID: 18999130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.